ArticleMolecular pharmaceutics2021

Multi-Immune Agonist Nanoparticle Therapy Stimulates Type I Interferons to Activate Antigen-Presenting Cells and Induce Antigen-Specific Antitumor Immunity.

Elizabeth S Levy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.